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BRIEF DEFINITIVE REPORT
Hematopoietic stem and progenitor cells are present
in healthy gingiva tissue
Siddharth Krishnan1, Kelly Wemyss1, Ian E. Prise1, Flora A. McClure1, Conor O’Boyle1, Hayley M. Bridgeman1, Tovah N. Shaw1,2,
John R. Grainger1, and Joanne E. Konkel1
Hematopoietic stem cells reside in the bone marrow, where they generate the effector cells that drive immune responses.
However, in response to inflammation, some hematopoietic stem and progenitor cells (HSPCs) are recruited to tissue sites and
undergo extramedullary hematopoiesis. Contrasting with this paradigm, here we show residence and differentiation of
HSPCs in healthy gingiva, a key oral barrier in the absence of overt inflammation. We initially defined a population of gingiva
monocytes that could be locally maintained; we subsequently identified not only monocyte progenitors but also diverse HSPCs
within the gingiva that could give rise to multiple myeloid lineages. Gingiva HSPCs possessed similar differentiation
potentials, reconstitution capabilities, and heterogeneity to bone marrow HSPCs. However, gingival HSPCs responded
differently to inflammatory insults, responding to oral but not systemic inflammation. Combined, we highlight a novel pathway
of myeloid cell development at a healthy barrier, defining a gingiva-specific HSPC network that supports generation of a
proportion of the innate immune cells that police this barrier.
Introduction
Our understanding of how immune cells are tailored to barrier
environments to support effective immunity has expanded
substantially in recent years. In particular, we are developing a
better understanding of the immune mechanisms reinforcing
the integrity of the mucosal barrier surrounding the teeth,
termed the gingiva (Moutsopoulos and Konkel, 2018). This is an
important advance, as loss of appropriate immune control in the
gingiva leads to the development of periodontitis, the most
common chronic inflammatory disease of humans (White et al.,
2012). This oral inflammatory disease poses a threat to overall
systemic health, as it has been linked to the exacerbation of a
plethora of other inflammatory conditions including cancer,
cardiovascular disease, and rheumatoid arthritis (Atarashi et al.,
2017; Konkel et al., 2019; Kostic et al., 2012). Thus, delineating
the local signals tailoring immune cell development and function
at the gingiva would not only promote the development of
therapies for periodontitis, but could also have implications for
the treatment of other inflammatory conditions.
Similar to other barriers, the gingiva is home to commensal
bacteria that must be effectively restrained in its niche. Yet the
gingiva is a unique barrier site with distinct innate cell dy-
namics. For example, neutrophils have previously been shown
to be the largest population of innate mediators policing this site
(Dutzan et al., 2016b), and it has been estimated that every
minute, 30,000 neutrophils extravasate from the gingiva into
the gingival sulcus, the external body space between the gingiva
and the tooth (Schiött and Löe, 1970). Surprisingly, how innate
immune populations are maintained at and effectively tailor-
ed to the gingiva has been minimally explored. One innate
cell population that exhibits exquisite capabilities for local,
tissue-specific adaptation are monocytes and their macrophage
progeny (Lavin et al., 2014). As such, we aimed to delineate
how these key immune cells were tailored to the gingival
environment.
Although some macrophage populations are generated early
in development and are locally maintained at barriers (Ginhoux
and Jung, 2014), circulating monocytes are also recruited from
the blood to barriers, where they differentiate into macrophages
(Bain et al., 2013; Tamoutounour et al., 2013). Monocytes de-
velop from bone marrow (BM)–resident hematopoietic stem
cells (HSCs) in specialized niches via controlled differentiation
of intermediate progenitor populations that lose self-renewing
capacity and become more restricted to the monocyte lineage.
Committed monocytes then enter the blood, where they circu-
late before recruitment to barrier sites (Guilliams et al., 2018). In
contrast to this conventional pathway of monocyte development,
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here we show that a large population of Ly6Chi monocytes in the
gingiva arose via a nonconventional pathway and could be locally
maintained. Importantly, we show that healthy, noninflamed
gingiva contained monocyte progenitors and HSCs that could
support the local production of not just monocytes, but other
short-lived myeloid cell populations. Previous studies have
shown that at steady state, a scarce population of circulating
hematopoietic stem and progenitor cells (HSPCs) constantly
surveys tissues and can trigger local hematopoiesis upon acti-
vation (Massberg et al., 2007). Stress, inflammation, and infec-
tion elicit retention of HSPCs in tissues and drive initiation of
this extramedullary hematopoiesis (EMH; Griseri et al., 2012;
Saenz et al., 2010), where the immune cells required to deal with
the inflammatory challenge are generated outside of the BM
environment. Contrasting with current understanding of he-
matopoiesis at barriers, herewe outline the presence of HSPCs in
healthy gingiva, in the absence of overt inflammation and/or
tissue perturbation. Gingival HSPCs were capable of differenti-
ating into numerous myeloid populations; in addition to mono-
cytes, neutrophils and other innate cells resident in healthy
gingiva could be locally maintained.
Our data demonstrate that HSPCs are present in healthy
gingival tissue, which, as defined by single-cell RNA-sequencing
(RNA-seq), are similar to those in the BM. Moreover, gingival
HSPCs possess an in vivo reconstitution ability and differenti-
ation potential similar to BM HSPCs. Despite this, gingiva and
BM HSPCs respond differently to inflammatory challenge. Gin-
giva HSPCs respond to local, oral inflammatory stimuli but re-
spond differentially to systemic inflammatory challenges that
remodel BM HSPCs. Importantly, our data demonstrate a bi-
furcation of innate cell generation during health, outlining a
novel pathway of innate cell generation that occurs in the
gingiva.
Results and discussion
A large population of barrier-resident monocytes are present
in healthy gingiva and exhibit unique developmental
requirements
In contrast to the gastrointestinal (GI) tract and skin, where cells
with a CD64+MHCIIhi macrophage phenotype dominate, most
lineage–CD11b+ cells present in the gingiva exhibited a classic
(Ly6Chi) monocyte-like phenotype despite the absence of in-
flammation (Fig. 1 A and Fig. S1, A and B). A dominance of
monocytes over macrophages was also seen by staining gingiva
tissue sections for immunofluorescence (Fig. S1, C and D). This
large putative Ly6Chi monocyte population was not in the blood
but the gingiva, as evidenced by minimal staining with anti-
CD45 following i.v. antibody injection (Fig. 1 B; Anderson
et al., 2014). A large monocyte population was also prominent
in the gingiva of another inbredmouse strain, specifically Balb/c
(Fig. S1 B). The Ly6Chi population expressed monocyte/macro-
phage markers but exhibited a monocyte-like cell morphology
distinct to that of purified gingival macrophages (Fig. S1, E and
F). A defining feature of blood and BM Ly6Chi monocytes is their
capacity to differentiate into F4/80+ macrophages. Suggestive of
their monocytic state, purified gingiva Ly6Chi cells were able to
differentiate into macrophages upon culture with M-CSF (Fig.
S1 G). Moreover, genome-wide transcriptional profiling of these
Ly6Chi cells compared with monocytes in the BM, blood, skin,
and GI tract further confirmed their monocyte identity, as they
expressed genes associated with the monocyte rather than the
macrophage lineage (Fig. S1 H; Ingersoll et al., 2010; Lavin et al.,
2014; Mildner et al., 2017). Taken together, these findings
demonstrate that a large population of monocytes is present in
healthy gingiva.
Comparative analysis of the gingiva monocytes to those pu-
rified from other body sites revealed that monocytes in the
gingiva were most similar to those in the BM, not other barrier
sites (Fig. 1 C), with a distinct gene cluster consisting of genes
up-regulated in only BM and gingival monocytes. This cluster
(cluster VI) was enriched in cell cycle genes, such as Cdk2, Cnn2a,
and Mcm family genes (Fig. 1 C) and gene ontology terms asso-
ciated with cellular replication (Fig. 1 D), suggesting that at least
a fraction of gingival monocytes, like in the BM (Hettinger et al.,
2013; Mildner et al., 2017), retain proliferative capacity. Com-
bined, these data outline a gingiva monocyte network that is
starkly different from that at other barrier sites.
To further explore the development of gingival monocytes,
we injected mice with a single dose of EdU and noted that,
similar to BM monocytes, gingiva monocytes were rapidly la-
beled (Fig. 1 E). Gingiva monocytes were labeled before those in
the blood, suggesting they were unlikely to seed this site via the
established development route where monocytes traffic from
the BM to blood before entering tissues. We also examined
Ccr2−/− mice, which have reduced circulating Ly6Chi monocytes
due to defective exit from the BM, causing deficiencies in tissue-
resident monocyte-derived populations (Serbina and Pamer,
2006). Gingiva monocytes were unchanged in these animals
(Fig. 1 F), further suggesting a distinct developmental pathway
for these cells.
We next used a head-shielded BM chimera approach to de-
termine whether gingival monocytes could be locally main-
tained. Host mice were irradiated with their heads shielded by
lead and then reconstituted with congenic BM. Following re-
constitution, most monocytes in the blood were donor derived;
however, more than half of gingival monocytes were host de-
rived (Figs. 1 G and S1 I). These data indicated that ∼50% of
Ly6Chi monocytes in the gingiva could be locally maintained.
This did not change with time: when head-shielded chimeras
were examined at ∼20 wk after reconstitution, the same pro-
portion of gingival monocytes were host derived (Fig. S1 J). This
local maintenance of a large proportion of monocytes in the
gingiva was unique to this barrier, as monocytes in the ear skin,
another shielded site in these chimeras, were predominantly
donor derived, similar to the blood (Fig. 1 G). Moreover, when
we examined chimerism of monocytes in the lung of torso-
shielded chimeras and GI tract of abdomen-shielded chimeras,
similar to the ear skin, monocytes exhibited high levels of chi-
merism (Fig. S1 K), further highlighting the distinct develop-
mental requirements of gingival monocytes relative to other
barrier sites.
Monocytes are short-lived immune effectors, usually rapid-
ly mobilized from the circulation to sites of inflammation;
Krishnan et al. Journal of Experimental Medicine 2 of 14
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Figure 1. A large population of monocytes is present in healthy gingiva. (A) Representative FACS plots showing monocytes (blue gate) and macrophages
(red gate) as a percentage of live CD45+Lin−CD11b+Ly6C+/−CD64+/− cells (excludes Ly6C−CD64− cells) in the gingiva and GI tract. In the skin, they were similarly
identified but were additionally CD24low, and the Ly6C/CD64 was gated on CCR2. n = 6–13 mice per group. Lin = CD3ε, TCR-β, CD19, B220, NK1.1, Ter119,
Krishnan et al. Journal of Experimental Medicine 3 of 14
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however, our data suggest a proportion of gingiva monocytes
were locally maintained. Given that the composition of the
gingival innate cell compartment is strikingly distinct from
other barrier sites (Fig. S1 L), we next queried whether this was
specific to this population or a feature of other short-lived im-
mune effectors present in healthy gingiva. We first examined
gingiva neutrophils in the head-shielded chimeras and saw that
a substantial proportion of these cells were also host derived
(Fig. 1 H). Again, this contrasted with what we saw in the ear
skin of head-shielded chimeras, where neutrophils were mainly
donor-derived, exhibiting the same chimerism as neutrophils in
the blood (Fig. 1 H). Moreover, substantial proportions of other
short-lived myeloid cells that could be identified in healthy
gingival tissue, specifically eosinophils and basophils, were host
derived in the head-shielded chimeras after reconstitution
(Fig. 1 I).
Combined, these data suggest that myeloid populations pre-
sent in healthy gingiva could be locally maintained, separate
from BM input. However, the presence of a BM source within
the skull could account for our findings, although this source
would need to differentially replenish cells within the ear skin
versus the gingiva (Fig. 1, G and H). To further examine possible
local generation of these myeloid populations in the gingiva, we
examined the larger populations of monocytes and neutrophils
in more detail. Within the gingival monocyte population, in
addition to some of these cells having proliferative capacity
(Fig. 1 E), we could identify common monocyte progenitors and
CXCR4+ premonocytes (Fig. 1, J and K; Chong et al., 2016). Along
these lines, in gingival tissue, we could also identify populations
of proliferating neutrophils (Fig. 1 L) and the recently defined
populations of and pre- and immature neutrophils (Figs. 1 M and
S1 M; Evrard et al., 2018). The presence of cells exhibiting
phenotypes of earlier stages of monocyte and neutrophil de-
velopment further indicated local development of these myeloid
cells in healthy gingival tissue.
HSPCs are present in healthy gingiva
To further explore the possibility that gingiva myeloid pop-
ulations could be locally generated, we assessed whether
gingival tissue contained myeloid cell progenitors or HSPCs that
could support this. Low numbers of circulating HSPCs con-
stantly survey tissues and can trigger local hematopoiesis upon
inflammation and infection, initiating EMH (Granick et al., 2012;
Massberg et al., 2007). As such, few HSPCs are resident in
healthy tissues at steady state. We isolated single-cell suspen-
sions from gingiva and, strikingly, identified HSPCs in this tis-
sue in the absence of overt inflammation (Fig. 2 A). This
included not only specific innate cell progenitors such as mye-
loid progenitor cells (MyP; gated as Lin−Sca-1−cKit+), common
myeloid progenitors (CMPs), and granulocyte-monocyte pro-
genitors, but also Lin−cKit+Sca-1+ (LSK) cells, multipotent pro-
genitor (MPP) cells (LSK, CD48+), and short- and long-term (LT)
HSCs (Fig. 2, A–C; and Fig. S2 A). Barrier-resident HSPCs were
not present in other healthy barriers examined (Fig. 2 D). Ad-
ditionally, we also identified gingival HSPCs in Balb/c mice (Fig.
S2 B). Importantly, the HSPCs identified were present within
gingival tissue, and not blood contaminants, as they did not label
with anti-CD45 injected i.v. (Fig. 2, E and F).
We have previously highlighted that local mechanical dam-
age is a key modifier of gingival immunity (Dutzan et al., 2017;
Krishnan et al., 2018), suggesting that steady state at the gingiva
is distinct from steady state at other barriers, with the gingiva
exhibiting signs of low-grade inflammation despite maintenance
of health. As such, we examined whether elevated gingival
damage could impact tissue-resident HSPCs. We assessed gin-
gival HSPCs in mice maintained on normal or hardened chow
diets (with mice on the harder diet experiencing elevated gin-
gival damage duringmastication). Inmice experiencing elevated
gingival barrier damage, there was an increase in the number of
long-term HSCs in the gingiva (Fig. S2 C). These data suggest
that the local damage experienced by the gingival barrier can
modify the local HSPC network, but combined, our data im-
portantly demonstrate that healthy, noninflamed gingival tissue
houses a diverse population of HSPCs.
Gingival HSPCs are capable of hematopoietic reconstitution
To confirm that the HSPC populations we identified in healthy
gingiva exhibited hematopoietic potential, we next dispersed
Siglec F, and Ly6G. (B) Representative contour plots of monocyte (Mos) labeling with i.v. administered, fluorescently conjugated CD45 antibody in the gingiva
and blood. n = 2–3 mice and representative of two independent experiments. (C and D)Monocytes were FACS purified from the blood, BM, gingiva, skin, and GI
tract and analyzed by RNA-seq. n = 2–3 biological replicates per group. (C) Hierarchical clustering of the gene expression profile of monocytes from the
indicated tissue sites. FPKM, fragments per kilobase per million mapped reads. (D) Pathway analysis of genes up-regulated bymonocytes in the BM and gingiva
identified in cluster VI by hierarchical clustering of their transcriptomic profiles using PANTHER and graphed according to enrichment score. FDR, false
discovery rate. (E) Frequencies of monocytes in the blood, BM, and gingiva labeled by a single dose of EdU administered in vivo. n = 4 mice per group from two
independent experiments. (F) Frequencies and total numbers of monocytes (Mo) in the gingiva and blood of control (white bars) and Ccr2−/− (gray bars) mice.
n = 3–7 mice per group from two independent experiments. (G–I) Head-shielded BM chimeras were generated by irradiating CD45.2 (host) mice with their
heads shielded by lead and reconstituting with CD45.1 (donor) BM. The proportions of donor-derived (white bar) and host-derived (black bar) monocytes (G),
neutrophils (H), and eosinophils and basophils (I) were examined in the blood (non-shielded site) and the gingiva and ear skin (both shielded sites) at 11–12 wk
after reconstitution. n = 6–11 mice per group from two to three experiments. (J) Representative pseudocolor plots identifying the common monocyte pro-
genitor (cMoP) in BM and gingiva. n = 2–5 mice from two independent experiments. (K) Representative FACS plots identifying premonocytes in the gingiva. n =
6 mice from three independent experiments. (L) Frequencies of neutrophils in the blood, BM, and gingiva labeled by a single dose of EdU 24 h following
administration. n = 4 mice per group from two independent experiments. (M) Representative FACS plots identifying preneutrophils and immature and mature
neutrophils in the gingiva. n = 3–4 mice from two independent experiments. Data are presented as mean ± SEM on graphs and FACS plots. Statistical
comparisons were performed using a two-way ANOVA with a Tukey’s post hoc test (E and G–I), unpaired t test with Welch’s correction (F, left panel),
Mann–Whitney U test (F, right panel), and a one-way ANOVAwith a post hoc Holm–Š́ıdák test (L); ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; and *, P < 0.05.
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single-cell suspensions of gingiva tissue in MethoCult medium.
Gingiva cells developed into CFU colonies, mainly of the
granulocyte-macrophage phenotype (Fig. 3, A and B), indicating
they possessed hematopoietic potential. Although the level of
hematopoietic activity present in the gingiva was lower than that
in the BM, it was substantially higher than that in other healthy
barrier tissues, which possess little hematopoietic potential (Fig.
S2 D). Flow-cytometric analysis of the colony-forming progeny
generated following MethoCult culture of gingiva and BM
preparations demonstrated the development of granulocytes and
monocytes (Fig. 3 C). These data demonstrate that healthy gin-
gival tissue houses cells with hematopoietic activity.
To explore the hematopoietic potential of gingiva relative to
BM HSPCs, we purified LSK and MyP from both tissues by flow
cytometry and cultured these cells in MethoCult medium. CFU
activity per cell was similar for HSPCs sorted from the gingiva
and BM (Fig. 3 D). Moreover, the progeny generated in these
cultures were similar when comparing gingiva and BM isolated
HSPCs (Fig. 3, E and F). Combined, these in vitro approaches
confirm that healthy gingival tissue itself houses cells with he-
matopoietic activity and that the in vitro hematopoietic activity
and differentiation potential of gingival HSPCs was similar to
BM HSPCs. We next ascertained whether gingival HSPCs were
capable of long-term multilineage reconstitution of hematopoiesis
Figure 2. HSPCs are present in healthy gingiva. (A) Representative contour plots for the gating strategy to identify HSPCs in the gingiva. Lin = CD3ε, TCR-β,
CD19, B220, NK1.1, Ter119, Siglec F, Ly6G, FcεR1α, CD11b, CD11c, and Ly6C. (B and C) Frequencies of HSCs (B) and MyP (C) in the BM and gingiva expressed as
a percentage of total CD45+ cells. n = 12 mice per group from four independent experiments. ST-HSC, short-term HSC; GMP, granulocyte-macrophage
progenitor. (D) Representative FACS plots showing HSPCs in the GI tract, skin, and gingiva. n = 3–6 from two independent experiments. Numbers show mean
frequencies (among CD45+) and SEM. (E and F) Representative contour plots of gingiva HSPCs labeling with i.v. administered fluorescently labeled CD45
antibody. (E) Gating on LSK and MyP plots show staining for CD45 antibody injected i.v. (F) Gating on all cells staining positive for CD45 antibody injected i.v.
and subsequent gating for LSK and MyP. Data are representative of two to three mice from three independent experiments. In all cases, numbers indicate
percentage of cells in the gate. Data are presented as mean ± SEM. Statistical comparisons were performed using an unpaired t test with Welch’s correction (B
and C); **, P < 0.01; *, P < 0.05.
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Figure 3. Gingival HSPCs are capable of hematopoietic reconstitution. (A–C) Single-cell suspensions from the BM (white bars) and gingiva (gray bars)
were cultured in MethoCult medium for 10 d. (A) CFU activity fromMethoCult cultures of total BM and gingiva tissue. (B) Representative photomicrographs of
MethoCult colonies from cultures of single-cell preparations from BM and gingiva. Scale bar = 500 µm. (C)Quantification of the lineage output fromMethoCult
cultures of BM and gingiva preparations determined by flow cytometry. n = 4–12 per group from six experiments. (D–F) FACS-sorted hematopoietic pro-
genitors were isolated from the BM and gingiva, and equal numbers of cells were seeded in MethoCult medium. (D) CFU activity of gingiva or BM FACS-sorted
Krishnan et al. Journal of Experimental Medicine 6 of 14
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in vivo. LSK and MyP were collectively sorted from the gingiva
and transplanted into sublethally irradiated, congenically dis-
tinct recipients alongside total BM cells from a third congenically
distinct donor (Fig. 3 G). Equal numbers of LSK and MyP cells
were also sorted from the BM and transferred in an identical way
into recipients to assess the capabilities of gingival versus BM
HSPCs. Following reconstitution, gingiva HSPC-derived cellular
progeny were identified in all organs examined (Fig. 3, H and I;
and Fig. S2, E and F) demonstrating that gingival HSPCs were
capable of surviving and generating progeny when transferred
into irradiated hosts. Gingival HSPCs were equally capable of
reconstitution compared with BM HSPCs, as they generated a
similar-sized population of CD45+ cells; this was true whether
examining engraftment at earlier (11–14 wk) or later (≥17 wk)
time points (Fig. 3 I). In line with this, examining the HSPC-
derived cells in the BM demonstrated a similar-sized popula-
tion of LSK andMyP cells in the BM of mice that received HSPCs
sorted from the gingiva and BM (Figs. 3 J and S2 G), demon-
strating equally efficient colonization of, and survival within,
BM niches. To determine the potential of the transferred HSPCs,
we examined the cellular identity of their progeny. Focusing on
the peripheral blood, BM, and spleen, multilineage reconstitu-
tion ability was seen for transferred HSPCs sorted from both BM
and gingiva (Figs. 3 K and S2 H). Moreover, similar frequencies
of the different immune lineages were generated by HSPCs from
both sources (Figs. 3 K and S2 H). These data highlight that the
transferred HSPCs possessed similar reconstitution capabilities
and differentiation potentials when they colonized the BM. This
was further confirmed in competitive BM chimeras, where
congenically distinct HSPCs from the BM and gingiva were co-
transferred into the same host. Examined 10–11 wk after recon-
stitution, there was no difference in reconstitution capacity of
HSPCs from either source (Fig. 3 L), and similar multilineage
reconstitution was also seen (Fig. S2 I). Combined, these data
demonstrate that healthy, noninflamed gingiva contains HSPCs
capable of colonizing the BM niche and reconstituting multiple
hematopoietic lineages.
Differential responsiveness of the BM and gingival
HSPC niches
Our data highlighted a surprising similarity between the func-
tional potentials of HSPCs in the gingiva and BM. To better
understand the similarity between the HSCs from the gingiva
and BM, we sort purified lineage-depleted LSK plus MyP
(CD45+Lin−cKit+) cells from both sites and analyzed gene ex-
pression of single cells. Aggregating all data points, we identified
14 cell clusters in an unbiased manner based on differentially
expressed genes (Fig. 4 A). Strikingly, comparison of gingiva and
BM HSCs on the 2D cluster projection demonstrated no major
differences in the subpopulations present at either site (Fig. 4 B).
Validating our single-cell RNA-seq approach, we noted a sepa-
ration of cells with gene modules for either an erythrocyte or
joint lymphoid-myeloid program (Fig. S3, A–D), as has been
previously described for lineage-depleted cKit+ cells in the BM
(Giladi et al., 2018). Moreover, we also identified gene modules
associated with the most naive HSC state (Giladi et al., 2018);
cells with a high stem score also had a low proliferation score
(Fig. 4, C and D). Expression of this naive HSC signature was
found in gingival CD45+Lin−cKit+ cells (Fig. 4, C and D), implying
that early HSCs were supported in this tissue and that healthy
gingiva is able to support a comprehensive HSPC network.
Having established that the cellular identities of the gingiva
and BMHSPC niches were similar, we next ascertained whether
stimuli important for establishing BM hematopoiesis were im-
portant for hematopoiesis in the gingiva. The presence of a
commensal flora and IFNα/β signaling are both required for
normal BM hematopoiesis (Balmer et al., 2014; Essers et al.,
2009; Khosravi et al., 2014). Similar to what has been de-
scribed in the BM, gingiva HSPCs were altered in germ-free
animals and animals in which IFNα/β signals were lacking
(Ifnar1−/− mice; Fig. 4, E and F). These data indicate that factors
important for regulating BM HSPCs are also important for gin-
gival HSPCs.
However, HSPCs are exquisitely responsive to inflammatory
stimuli, being remodeled by inflammation to provide the im-
mune effectors needed for an immune response (Baldridge et al.,
2010; Griseri et al., 2012; Nagai et al., 2006; Saenz et al., 2010;
Siracusa et al., 2013). Therefore, we next queried whether gin-
gival and BM HSPCs would similarly respond to inflammatory
stimuli. First, we induced inflammation local to the gingiva,
using ligature-induced periodontitis (LIP) to drive oral inflam-
mation (Abe and Hajishengallis, 2013). In response to local in-
flammation, gingiva HSPCs expanded (Fig. 4 G), resulting in
increased hematopoietic activity in gingival tissue and therefore
cells. (E and F) Quantification of the lineage output from MethoCult cultures of FACS-sorted LSK (cKit+Sca1+) and MyP (cKit+Sca1−). Data representative of
three independent experiments. (G) Schematic of the generation of whole-body chimeras. Anesthetized CD45.1/2 hosts were sublethally irradiated and re-
ceived equal numbers of LSK + MyPs FACS sorted from the gingiva or BM of CD45.2 mice alongside total BM cells from CD45.1 mice. (H) Representative FACS
plots identifying gingiva HSPC-derived CD45.2+ cells within total CD45+ cells (both CD45.1 and CD45.2) in the BM, blood, and spleen. (I) Quantification of BM
and gingiva HSPC-derived cellular progeny in the indicated tissues expressed as a percentage of the total CD45+ population, at early time points (11–14 wk,
solid bars) and late time points (≥17 wk, hatched bars) after reconstitution. n = 5–12 mice/group from two to three independent experiments for each time
point. (J) Frequencies of BM LSK and MyPs that were derived from BM-HSPCs or gingiva-HSPCs examined 11–14 wk after reconstitution. Data expressed as a
percentage of total donor HSPC-derived cells. n = 5–6 mice per group from two independent experiments. (K) Lineage output of BM and gingiva HSPC-derived
progeny in the BM, blood, and spleen at 11–14 wk after reconstitution, expressed as a percentage of total donor HSPC-derived cells. n = 5–6 mice per group
from two independent experiments. (L) Left: Equal numbers of LSK + MyPs were sorted from the BM of CD45.1 mice and gingiva of CD45.1/2 mice and
transferred into sublethally irradiated CD45.2 hosts who also received total CD45.2 BM cells. Mice were reconstituted for 10–11 wk, after which the proportion
of BM- or gingiva-derived cells was analyzed by FACS. Right: Proportions among all CD45.1 cells of BM- and gingiva-derived progeny in the BM, blood, and
spleen. n = 5/group from two independent experiments. Data are presented as mean ± SEM except in K, where mean frequencies of HSPC-derived progeny are
plotted. Statistical comparisons were performed using an unpaired t test withWelch’s correction (A and J), a two-way ANOVAwith a post hoc Holm–Š́ıdák test
(C–F, K, and L), and Tukey’s test (I); *, P < 0.05. We acknowledge Servier Medical Art (https://smart.servier.com) for cartoons used in this figure.
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Figure 4. BM and gingiva HSPCs exhibit distinct responsiveness to inflammation. (A–D) Total LSK + MyP cells were isolated by FACS from the gingiva
and BM of mice and analyzed by single-cell RNA-seq. (A) tSNE plots show clustering in the two tissues. (B) Bar graph showing frequencies of cells in each
cluster in BM (white bars) and gingiva (gray bars) samples. (C and D) Projection of the stemness and cell cycling index scores (from Giladi et al., 2018) onto the
core model to identify their distribution across the clusters in the BM and gingiva. (E and F) Number of LSKs and MPPs in the BM per femur and gingiva of
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increased CFU activity per cell in MethoCult assays (Fig. 4 H).
Importantly, this HSPC remodeling driven by oral inflammation
was gingiva specific, as no changes to HSPC populations were
seen in the BM of LIP mice (Fig. 4, G and H). Focusing on the
expanded HSPC network in the gingiva, we noted an altered
differentiation potential, with increased production of neu-
trophils in Methocult assays of gingiva from LIP compared with
controls (Fig. 4 I). To explore this altered differentiation po-
tential further, we sorted LSK and MyP from LIP and control
mice and cultured these cells in MethoCult medium. LSK from
LIP mice exhibited increased CFU capacity and generated in-
creased proportions of neutrophils (Fig. S3, E and F). Examining
this in vivo, we transferred total HSPCs (i.e., LSK + MyP) from
control or LIP mice, alongside total BM cells from a third con-
genically distinct donor, into irradiated recipients. When re-
constitution was examined after 10 wk, HSPCs from LIP mice
gave rise to increased proportions of neutrophils, although no
increases in reconstitution capacity were seen (Fig. S3, G and H).
Combined, these data outline clear alterations to the local,
gingiva-resident HSPC network in response to oral inflamma-
tion; such alterations are specific to this site and not seen in BM
HSPCs.
Next, we ascertained whether inflammatory stimuli shown
to remodel the BM niche could impact gingival HSPCs. Recently,
β-glucan has been shown to drive trained immunity through
modulation of BM HSPCs and hematopoiesis (Mitroulis et al.,
2017). We injected mice with β-glucan and saw the previously
described increases in BM HSPC populations (Mitroulis et al.,
2017; Fig. 4 J). These changes in BM HSPCs in response to
β-glucan were tissue specific; gingival HSPCs were unchanged
following β-glucan administration (Fig. 4 J). Exploring the im-
pact of systemic inflammation on gingival hematopoiesis fur-
ther, we injected mice with LPS, a stimulus shown to drive more
substantial changes to BM HSPCs. LPS injection induced the
previously reported expansion of LSK in the BM (Fig. S3 I;
Scumpia et al., 2010). Again, this was not seen in the gingival
HSPC compartment (Fig. S3 I). However, the gingival HSPC
niche did exhibit decreases inMyP that were also seen in the BM
HSPC niche (Fig. S3 J). Combined, these data highlight that
healthy gingiva houses HSPCs that, in response to local in-
flammation, are remodeled to promote enhanced production of
neutrophils. In contrast, our data demonstrate that in response
to systemic inflammatory stimuli, the gingival HSPC niche re-
sponds differently from the BM niche. Indeed, gingiva HSPCs
were protected from certain systemic inflammatory stimuli ca-
pable of altering output of innate cells from the BM.
Circulating HSPCs are retained within inflamed tissues
(Massberg et al., 2007); sensitive to signals of tissue distress,
HSPCs become tissue resident and undergo EMH to generate
effector cells that contribute to the ongoing inflammatory re-
sponse (Griseri et al., 2012; Saenz et al., 2010; Siracusa et al.,
2013). In this way, EMH is a key mechanism of effective im-
munity. As such, at barrier sites, EMH has been shown to occur
in response to pathogen challenge and injury (Fu et al., 2019;
Kim et al., 2011; Saenz et al., 2010; Siracusa et al., 2013). More-
over, HSPCs resident in inflamed barriers have been shown to
be mediators of the pathophysiological network driving disease
in a number of settings (Griseri et al., 2012; Siracusa et al., 2013).
Standing in contrast to these pivotal roles for extramedullary
HSPCs in contributing to active inflammation, we demonstrate
that HSPCs are present in healthy gingiva tissue. The HSPCs
identified in gingival tissue were present in the absence of any
current or past inflammatory challenge, in naive animals that
had no history of inflammation. In health, few tissues support
EMH; predominantly during development, but also later in life,
the liver, spleen, and muscle can house HSPCs (Cardier and
Barberá-Guillem, 1997; McKinney-Freeman et al., 2002;
Morrison et al., 1997). Of particular interest, the lung has been
shown to be a reservoir for megakaryocytes and HSPCs that are
important for platelet generation (Lefrançais et al., 2017), and
fetal skin can support megakaryocyte-erythroid-mast cell pro-
genitors and erythropoiesis (Popescu et al., 2019). Distinct from
this, we show local generation of multiple populations of short-
lived myeloid cells at a healthy barrier site, which then consti-
tute components of the local immune network. Moreover, we
show that the gingiva houses naive HSCs, not just later pro-
genitor stages that are supplied by the BM. These data highlight
a unique mechanism of myeloid cell development and instruc-
tion at the gingiva. Our studies should now be extended to ex-
amine human gingiva, ascertaining the role of gingival
hematopoiesis on human oral health.
What would be the biological necessity for the gingiva to
support the local development of a proportion of myeloid cells?
The gingiva exhibits a very high demand for innate cells at
steady state, with large populations of both neutrophils and
monocytes present. Indeed, there are much larger populations of
monocytes and neutrophils in the gingiva than any other healthy
barrier. Although we have not detailed the lifespans or ultimate
fates of these populations in the gingiva, it could be hypothe-
sized that generation of these short-lived innate immune medi-
ators would ordinarily place a high demand on BM hematopoiesis,
a process that must be strictly controlled to prevent BM HSC
exhaustion. Relocating production of innate cells from the BM to
the gingiva would reduce the stress placed on the BM niche and
concomitantly safeguard the function of gingiva-generated in-
nate cells from distal/systemic inflammatory signals. In addition
germ-free (GF) mice and specific pathogen–free (SPF) controls (E) or Ifnar1−/− and controls (F). n = 6–9 mice per group. (G–I) LIP was induced in cohorts of
mice, and HSPCs in the gingiva and BMwere examined 10 d after ligature placement. (G) Graph shows fold-change in the numbers of LSK, MyP, and MPP cells
in the gingiva and BM. n = 6 mice per group pooled from two independent experiments. (H) CFU activity from MethoCult cultures of BM (left) and gingiva
(right). n = 6 mice pooled from four independent experiments. (I) Neutrophil output in MethoCult cultures of gingiva and BM assessed by flow cytometry. n = 6
mice per group pooled from four independent experiments. (J) Fold-change in the numbers of LSK, MyP, and LT-HSCs in the gingiva and BM 7 d following i.p.
administration of β-glucan. n = 5–7 mice per group pooled from three independent experiments. Data are presented as mean ± SEM. Statistical comparisons
were performed using an unpaired t test (E and J) with Welch’s correction (F, H, and I), a two-way ANOVA with a Holm–Š́ıdák post hoc test (G). ***, P < 0.001;
**, P < 0.01; *, P < 0.05.
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to this, locally generated innate cells could exhibit altered
functions, exquisitely tailored to promote gingival health, a key
future line of inquiry.
Combined, our data indicate that some myeloid cells, in-
cluding monocytes and neutrophils, present in the gingiva de-
velop locally from barrier-resident HSPCs. Together, our data
outline a unique mechanism that enforces local control over the
innate immune cells policing the gingival barrier, redefining our
understanding of how innate immune cells develop and are in-
structed to appropriately function at this site.
Materials and methods
Mice
C57BL/6 were purchased from Envigo. Ccr2−/− (originally from
The Jackson Laboratory), Ifnar1−/−(Müller et al., 1994; provided
by C. Reis e Sousa, The Francis Crick Institute, London, UK),
congenic CD45.1 C57BL/6, and congenic CD45.1/CD45.2 C57BL/6
mice were bred in house. Germ-free mice and specific pathogen–
free controls were obtained from the University of Manchester
Axenic and Gnotobiotic Facility. All experiments were ap-
proved by the University of Manchester AnimalWelfare Ethical
Review Body and the Home Office, UK, and performed fol-
lowing local rules. All mice, except germ free, were housed
under specific pathogen–free conditions, and all experiments
used age- and sex-matched animals.
Generation of chimeras
For head-shielded chimeras, host mice were anesthetized by i.p.
administration of ketamine (80 mg/kg; Vetoquinol) and xyla-
zine (8 mg/kg; Bayer). Mice received either total-body irradia-
tion or were irradiated with their heads positioned beneath lead
shielding. In both cases, mice received a total of 11 Gy irradiation
as a split dose. Mice were reconstituted by i.v. injection with
5–10 × 106 donor BM cells from congenic animals that had been
depleted of CD90 cells by MACS microbeads (Miltenyi Biotec)
according to the manufacturer’s instructions. For experiments
examining the differentiation potential of sorted HSPC pop-
ulations, 200 or 500 FACS-purified CD45+Lin−cKit+ cells were
transferred alongside 4–5 × 106 congenic donor BM. Mice were
maintained on 0.03% enrofloxacin (Bayer) supplied through
drinking water 1 wk before and 4 wk after irradiation. After
irradiation, mice were housed in autoclaved cages with sterile
drinking water, food, bedding, and enrichment. Reconstitution
was allowed to occur for a minimum of 8 wk before analysis.
LIP
Bone loss was induced through the use of a 5-0 silk ligature tied
around the maxillary second molars, with the ligature placed in
the gingival sulcus as previously described (Abe and Hajishengallis,
2013); this treatment induces bone loss, which was measured 10 d
after ligature placement.
In vivo treatments
Mice were i.p. dosed with 1 mg of β-glucan (InvivoGen) dis-
solved in sterile water and euthanized 7 d after treatment to
harvest tissues. For in vivo CD45 labeling experiments, mice
received 1 µg anti–CD45-AF700 (BioLegend) i.v. and were eu-
thanized 5 min after treatment. For EdU labeling experiments,
mice were i.p. dosed with 0.5 mg EdU (Life Technologies) per
mouse and euthanized 4 or 24 h after treatment. Mice were i.p.
dosed with 5 µg LPS (Escherichia coli O111:B4; InvivoGen) and
euthanized 18 h after treatment.
Preparation of single-cell suspensions
Gingiva
Mouse gingiva were dissected as previously described (Dutzan
et al., 2016a). Briefly, tissue blocks were dissected and digested
for 30 min at 37°C in RPMI 1640 (Sigma-Aldrich; henceforth
called medium) supplemented with 2 mM L-glutamine (Sigma-
Aldrich), 10 mM Hepes (Sigma-Aldrich), 3.2 mg/ml collagenase
IV (Gibco), and 7.5 µg/ml DNase (Sigma-Aldrich). Following
removal of gingiva tissue from maxilla and mandible, single-cell
suspensions were obtained by mashing tissues through a 70-µm
cell strainer.
Blood
Blood was harvested by cardiac puncture into medium con-
taining 6.25 mM EDTA (Sigma-Aldrich) supplemented with 3%
FCS. Red blood cells were lysed by incubation with ammonium-
chloride-potassium lysing buffer (Lonza) for 3 min on ice twice.
BM
Single-cell suspensions were prepared from the BM by flushing
the marrow out of femurs, followed by red blood cell lysis as
described above.
Small intestine and colonic lamina propria
Cells were isolated as previously described (Shaw et al., 2018).
Briefly, the small intestine and colon were rapidly dissected,
Peyer’s patches removed, longitudinally cut, and washed in PBS.
Intestinal epithelial cells were removed by chopping tissues into
2–3-cm segments, which were incubated for 20 min at 37°C with
vigorous agitation in medium containing 3% FCS, 20 mMHepes,
100 U/ml polymyxin B (Sigma-Aldrich), 5 mM EDTA, and 1 mM
freshly thawed dithiothreitol. After incubation, tissues were
repeatedly shaken in fresh serum-free medium with 2 mM
EDTA and 20 mM Hepes to further dissociate intestinal epi-
thelial cells and leukocytes. The remaining lamina propria and
muscularis were minced and digested (37°C, 30 min) with con-
tinuous stirring in serum-free medium with 20 mM Hepes,
0.1 mg/ml Liberase TL (Roche), and 0.5 mg/ml DNase. The tissue
was mashed through a 70-µm cell strainer and subsequently a
40-µm cell strainer to obtain single-cell suspensions.
Skin
The dorsal and ventral sides of the ear were separated. This
tissue was digested in mediumwith 0.25 mg/ml Liberase TL and
0.5 mg/ml DNase for 105 min at 37°C. The reaction was stopped
with 0.5 M EDTA, and the tissue was processed with a Medi-
Machine (BD Biosciences) system for 6 min. Cell suspensions
from Medicons were washed with 8 ml complete medium with
0.5 mg/ml DNase and passed through a 100-µm strainer to ob-
tain a single-cell suspension.
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Spleen and submandibular lymph nodes
Spleens and lymph nodes were mashed through a 70-µm
strainer. For spleens, red blood cells were lysed as described
above.
Lung
Lungs were finely minced and incubated in medium with
0.1 mg/ml Liberase TL and 0.25 mg/ml DNase for 20min at 37°C
in a shaking incubator. Cells were mashed through a 70-µm cell
strainer, and red blood cells were lysed and washed to obtain a
single-cell suspension.
Flow cytometry
Single-cell suspensions from tissues were washed in PBS and
incubated with antibody cocktails in FACS buffer (PBS with 2%
FCS and 2mMEDTA) or PBSwith anti-CD16/32 (2.4G2; BioXcell)
for 15 min at 4°C. Dead cells were excluded by use of a Live/Dead
Fixable blue dead cell stain kit (Molecular Probes), Zombie
UV, or Aqua Fixable Viability Kit (BioLegend). When biotin-
conjugated antibodies were used, cells were washed and
stained with fluorochrome-conjugated streptavidin (BioLegend)
for 10 min at 4°C. Cells were fixed in 2% paraformaldehyde
(Sigma-Aldrich) for 10 min at room temperature, washed, and
finally resuspended in PBS before acquisition. EdU staining was
performed after fixation using Click-iT EdU Cell Proliferation
Kit (Thermo Fisher Scientific) according to the manufacturer’s
instructions. Cell were stained with combinations of the fol-
lowing antibodies, which were obtained from eBioscience, BD
PharMingen, and BioLegend: CD45 (30-F11), CD45.1 (A20), CD45.2
(104), CD3ε (145-2C11), TCR-β (H57-597), CD19 (1D3), B220 (RA3-
6B2), Ly6G (1A8), NK1.1 (PK136), Ter119 (TER-119), Siglec F (E50-
2440), FcεR1α (MAR-1), CD49b (HMα2), CD11b (M1/70), Ly6C
(HK1.4), CD64 (X54-5/7.1), F4/80 (BM8), CX3CR1 (SA011F11), CD44
(IM7), CCR2 (SA203G11), CD68 (FA-11), I-A/I-E (M5/114.15.2),
CD11c (N418), Sca-1 (D7), cKit (2B8), CD150 (TC15-12F12.2), CD48
(HM48-1), Flt3 (A2F10), CD34 (RAM34), CD16/32 (93), CD101
(Moushi101), CXCR4 (L276F12), CD27 (LG.3A10), and CD201 (1560).
Samples were acquired using a BD LSRFortessa or FACSymphony
(BD Biosciences) flow cytometer and analyzedwith FlowJo software
(TreeStar). Where appropriate, dimensional reduction was per-
formed using the t-distributed stochastic neighbor embedding
(tSNE) algorithm in FlowJo.
Monocytes were identified as CD45+Lin− (CD3ε, TCR-β, CD19,
B220, NK1.1, Ter119, Siglec F, and Ly6G) CD11b+Ly6ChiCD64−MHCII−.
HSPCs were identified as follows: LSK, CD45+Lin− (CD3ε, TCR-β,
CD19, B220, NK1.1, Ter119, Siglec F, Ly6G, FcεR1α, CD11b, CD11c,
and Ly6C) Sca-1+cKit+; MyP, CD45+Lin−Sca-1−cKit+; long-term
HSC, LSK CD150+CD48−; short-term HSC, LSK CD150−CD48−;
MPP, LSK CD150−CD48+; MPP4, LSK Flt3+CD48+; granulocyte-
monocyte progenitor, MyP CD16/32hiCD34+; and CMP, MyP
CD16/32intCD34+.
Monocyte and HSPC isolation by FACS
Single-cell suspensions of blood, BM, gingiva, skin, and the small
intestine were prepared as previously described and suspended
in FACS buffer. Cells were sorted using a BD FACSAria Fusion
(BD Biosciences). Monocytes were sorted using the same gating
as in Fig. S1 A, and HSPCs were sorted using the strategy out-
lined in Fig. 2 A. For cytospins, MethoCult, chimera experi-
ments, and macrophage differentiation cultures, cells were
collected in complete RPMI with 10% FCS. For bulk RNA-seq
experiments, cells were collected in RLT buffer (Qiagen) con-
taining β-mercaptoethanol. Cells were collected in 50% RPMI/
50% FCS for single-cell sequencing experiments.
M-CSF macrophage-monocyte cultures
Monocytes sorted from the gingiva or BM were cultured for 7 d
in 96-well round-bottom plates (Corning) in RPMI 1640 sup-
plemented with 10 mM Hepes, 100 U/ml penicillin, 100 µg/ml
streptomycin, 2 mM L-glutamine, MEM nonessential amino
acids, 10% FCS, and 20 ng/ml M-CSF (Peprotech). Cells were
washed with PBS and detached using Accutase (StemCell
Technologies) according to the manufacturer’s instructions and
were analyzed by flow cytometry.
Bulk RNA-seq
Total RNA from ∼700–40,000 FACS-sorted monocytes was
isolated using the Single Cell RNA Purification Kit (Norgen Bi-
otek Corp.) according to the manufacturer’s instructions. RNA
samples were precipitated adding 0.1 volume of 3 M sodium
acetate and 2 volumes of 100% ethanol and shipped on dry ice to
Theragen Etex Bio (South Korea) for sequencing. Briefly, cDNA
libraries were generated using the SMART-Seq V3 Ultra Low
Input RNA Kit (CloneTech), and samples were sequenced on the
Illumina HiSeq2500PE sequencing platform. Reads were filtered
with Trimmomatic (v0.36). Filtered fastq files were aligned to
the GENCODE genome (GRCm38.p5) using STAR (v2.5.3). Fil-
tered reads were then sorted, compressed, and unaligned reads
removed using samtools (v0.1.18). Aligned reads were then
counted, normalized, and compared using the Cuffquant, Cuff-
norm, and Cuffdiff functions, respectively, of Cufflinks (v2.2.1).
Genes were clustered using Morpheus (Broad Institute, https://
software.broadinstitute.org/morpheus/). The enrichment of
gene ontology terms was determined using Panther. ArrayEx-
press accession no. E-MTAB-10039.
Single-cell RNA-seq
Single-cell isolation and library construction
Single-cell suspensions of gingival and BM HSPCs were FACS
purified. Gene expression libraries were prepared from single
cells using the Chromium Controller and Single Cell 3ʹ Reagent
Kit v3 (10x Genomics) according to the manufacturer’s protocol.
Briefly, nanoliter-scale gel beads in emulsion (GEMs) were
generated by combining barcoded gel beads, a master mix con-
taining cells, and partitioning oil onto a chromium chip. Cells
were delivered at a limiting dilution, such that the majority
(90–99%) of generated GEMs contain no cells, while the re-
mainder largely contain a single cell. The Gel Beads were then
dissolved, primers were released, and any copartitioned cells
were lysed. Primers containing an Illumina TruSeq Read 1 se-
quencing primer, a 16-nt 10x Barcode, a 12-nt unique molecular
identifier, and a 30-nt poly(dT) sequence were then mixed with
the cell lysate and a master mix containing reverse transcription
reagents. Incubation of the GEMs then yielded barcoded cDNA
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from polyadenylated mRNA. Following incubation, GEMs were
broken, and pooled fractions were recovered. First-strand cDNA
was then purified from the post-GEM–reverse transcription
reaction mixture using silane magnetic beads and amplified via
PCR to generate sufficient mass for library construction. Enzy-
matic fragmentation and size selection were then used to opti-
mize the cDNA amplicon size. Illumina P5 and P7 sequences, a
sample index, and TruSeq Read 2 sequence were added via end
repair, A-tailing, adaptor ligation, and PCR to yield final
Illumina-compatible sequencing libraries.
Sequencing
The resulting sequencing libraries comprised standard Illu-
mina paired-end constructs flanked with P5 and P7 sequences.
The 16-bp 10x Barcode and 12-bp unique molecular identifier
were encoded in Read 1, while Read 2 was used to sequence the
cDNA fragment. Sample index sequences were incorporated as
the i7 index read. Paired-end sequencing (28:98) was per-
formed on the Illumina NextSeq500 platform using NextSeq
500/550 High Output v2.5 (150 Cycles) reagents. The .bcl se-
quence data were processed for quality control purposes using
bcl2fastq software (v2.20.0.422), and the resulting .fastq files
were assessed using FastQC (v0.11.3), FastqScreen (v0.9.2), and
FastqStrand (v0.0.5) before preprocessing with the CellRanger
pipeline.
Data processing
Cells with >10% mitochondrial reads were filtered out. The re-
maining cells were normalized, integrated (using IntegrateData),
and analyzed with Seurat (v3.0). Module enrichment is presented
as the transcript count of the genes comprising the cell module
over the total transcript count of each cell and visualized using
FeaturePlot (Seurat v3.0). On average, 3,360 genes for the gingiva
and 3,096 genes for the BM were detected per cell. ArrayExpress
accession no. E-MTAB-10050.
MethoCult assays
Total cell preparations from tissues or flow cytometry–purified
HSPC populations were suspended in methylcellulose medium
to quantify clonogenic CFUs (MethoCult GF M3434; StemCell
Technologies). Cultures were incubated at 37°C with 5% CO2 for
9–10 d before colonies were assessed and counted using an in-
verted microscope. Images of colonies were taken at 4×/UPlanFL
N objective on the bright-field setting of an Olympus MMI Cell
Cut Laser Microdissection System and white balanced using
MMI CellTools software.
Cytospin
Monocytes and macrophages FACS purified from the gingiva
were mounted on Superfrost slides (Thermo Fisher Scientific)
using a Cytospin centrifuge (Cytospin 4; Thermo Fisher Scien-
tific). Cells were fixed with ice-coldmethanol and stored at room
temperature before staining with hematoxylin and acidic eosin
(Thermo Fisher Scientific) and mounted with DPX (Thermo
Fisher Scientific). Images were captured using an Olympus BX63
upright microscope. Images were then processed and analyzed
using Fiji ImageJ.
Immunofluorescent imaging
Gingiva was fixed for 24 h in 4% paraformaldehyde (Sigma-
Aldrich) before decalcification in Osteosoft (Merck Millipore)
and storage in 70% ethanol until processing. Paraffin-embedded
sections were deparaffinized and rehydrated. Antigen retrieval
was performed through incubation with trypsin (1 mg/ml; for
Ly6G) or proteinase K (20 µg/ml; for F4/80 and Ly6C) for 15 min
at 37°C. Avidin biotin blocking was performed as per the man-
ufacturer’s instructions (BioLegend) before incubation with
primary antibodies against Ly6C (0.7 mg/ml; Abcam), Ly6G
(0.32 mg/ml; Abcam), and F4/80 (0.5 mg/ml; Invitrogen)
overnight at 4°C. Sections were incubated with appropriate bi-
otinylated secondary antibodies before performing tyramide
AF555 amplification as per the manufacturer’s instructions
(Invitrogen). Sections were counterstained with DAPI (1 µg/ml)
and mounted. Images were collected at room temperature on a
Zeiss Axioimager.D2 upright microscope using either a 5×/0.16
EC Plan-neofluar or 10×/0.3 EC Plan-neofluar objective and
captured using a Photometrics Coolsnap HQ2 camera through
Micromanager software v1.4.23. Images were processed with Fiji
Image J v2.1.0/1.53c following acquisition.
Statistics
Statistical analyses were performed using GraphPad Prism 7/8,
and data are presented as mean ± SEM in all cases unless oth-
erwise indicated. Statistical testing between two groups was
performed using a Student’s t test for paired experimental data,
an unpaired t test with Welch’s correction, or a Mann–Whitney
U test. When comparing more than two groups, a one-way
ANOVA or a two-way ANOVA with appropriate post hoc tests
was used.
Online supplemental material
Fig. S1 shows that a unique monocyte population is present in
the gingiva. Fig. S2 shows that HSPCs are present in gingiva
tissue and exhibit hematopoietic activity. Fig. S3 details how
HSPCs in the gingiva and BM exhibit altered responsiveness to
inflammatory signals.
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Figure S1. A unique monocyte population is present in the gingiva. (A) Gating strategy to identify monocytes in the gingiva and GI tract (numbers indicate
frequencies expressed as mean ± SEM). (B) Quantification of monocytes as a percentage of live CD45+Lin−CD11b+Ly6C+/−CD64+/− cells (excludes Ly6C−CD64−
cells) in the gingiva of C57BL/6 and Balb/c mice and GI tract and skin of C57BL/6 mice. n = 6–13 mice per group. Lin = CD3ε, TCR-β, CD19, B220, NK1.1, Ter119,
Siglec F, and Ly6G. (C and D) Representative staining of gingiva tissue for Ly6G+, Ly6Cbright, and F4/80+ cells. (C) Images show locations of cells staining
positive for each marker. (D) Representative sections stained for Ly6G, Ly6C, and F4/80. Solid white line indicates edge of tooth. Scale bar = 200 µm. Staining
from three separate experiments with n = 2–3 per experiment. (E) Representative histograms showing staining for CD44, CD68, CCR2, and CX3CR1 by gingival
Ly6Chi monocytes (Mo). Data from seven experiments with two to three mice per experiment. FMO, fluorescence minus one. (F) Cytospins of sorted gingival
Ly6Chi monocytes andmacrophages (Mϕ) stained with H&E. Scale bar = 10 µm. Images are representative of two independent experiments. (G) Representative
FACS plots of sorted BM and gingiva monocytes that were cultured with M-CSF for 7 d and analyzed by FACS. Data from two independent experiments. (H)
Monocytes were FACS purified from the blood, BM, gingiva, skin, and GI tract and analyzed by RNA-seq. n = 2–3 biological replicates per group. Heatmap of the
expression profile of canonical monocyte and macrophage-associated genes. FPKM, fragments per kilobase per million mapped reads. (I) Representative FACS
plots showing host- and donor-derived Ly6Chi monocytes in the blood and gingiva of head-shielded chimeras 20 wk after reconstitution. Numbers indicate
percentage of cells in the gate. (J) Quantification of donor-derived (white bar) and host-derived (black bar) Ly6Chi gingival monocytes 12 and 20 wk after
reconstitution in head-shielded chimeras. n = 6–11 mice per group from two to three experiments. (K) Chimerism of Ly6Chi monocytes in the lungs of torso-
shielded chimeras (left) and GI tract of abdomen-shielded chimeras (right). The frequency of donor-derived Ly6Chi gingiva monocytes was normalized to that of
blood Ly6Chi monocytes to determine percent chimerism. Data from one to two experiments with n = 3–9 mice per group. (L) Proportions of innate cells
presented as the percentage of all CD45+ cells in the gingiva, GI tract, and skin. n = 3 from three independent experiments. Asterisks indicate significant
differences compared with gingiva. (M) tSNE map of CD45+Lin−Ly6G+ gingival cells that were subjected to dimensional reduction based on Sca-1, cKit, CXCR2,
CD45, Ly6G, CXCR4, MHCII, CD11b, Ly6C, CD11c, CD101, and Lin. Identified subpopulations are highlighted in the tSNE plot. Data representative of two
experiments with n = 2–3 mice. Data are presented as mean ± SEM. Statistical comparisons were performed using a one-way ANOVA with a post hoc Tukey’s
test (B) and a two-way ANOVA with a Tukey’s (L) and Holm–Š́ıdák post hoc test (J); ****, P < 0.0001; **, P < 0.01; *, P < 0.05.
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Figure S2. HSPCs are present in gingival tissue and exhibit hematopoietic activity. (A) Number of HSCs in the BM per femur and gingiva. n = 12 mice per
group pooled from four independent experiments. (B) Left: Representative FACS plots identify HSPCs in the gingiva of C57BL/6J and Balb/c mice. Numbers
indicate frequencies of HSPCs among Lin−cKit+ cells. Right: Frequencies of HSPCs in the gingiva of C57BL/6J and Balb/c mice expressed as a percentage of total
CD45+ cells. n = 4–6 per group. Lin = CD3ε, TCR-β, CD19, B220, NK1.1, Ter119, Siglec F, Ly6G, FcεR1α, CD11b, CD11c, and Ly6C. (C) Absolute number of LT-HSCs
from mice fed normal or a hardened chow diet for 8 wk. n = 8–9 mice per group pooled from three independent experiments. (D) CFU activity from MethoCult
cultures of gingiva and small and large intestines. n = 2–6 per group pooled from four experiments. (E–H) CD45.1/2 hosts were sublethally irradiated and
received equal numbers of LSK + MyPs FACS-sorted from the gingiva or BM of CD45.2 mice alongside total BM cells from CD45.1 mice. (E) Table showing
numbers of chimera hosts into which HSPCs from either BM or gingiva were transferred and details of engraftment of the transferred HSPCs. (F) Bar graph
showing frequencies of BM and gingiva HSPC-derived progeny in the indicated tissues expressed as a percentage of the total CD45+ population examined 11–14
wk (left) or ≥17 wk (right) after reconstitution. n = 3–6 mice per group from two independent experiments. SMLN, submandibular lymph node. (G) Bar graphs
show frequencies of BM LSKs and MyPs that were derived from BM-HSPCs (white bars) or gingiva-HSPCs (gray bars) examined ≥17 wk after reconstitution.
Data expressed as a percentage of total donor HSPC-derived cells. n = 5–8 mice per group from three independent experiments. (H) Lineage output of BM and
gingiva HSPC-derived progeny in the BM, blood, and spleen at ≥17 wk after reconstitution, expressed as a percentage of total donor HSPC-derived cells. n =
7–12 mice per group from three independent experiments. (I) Equal numbers of LSK + MyPs were sorted from the BM of CD45.1 mice and gingiva of CD45.1/
2 mice and transferred into sublethally irradiated CD45.2 hosts who also received total CD45.2 BM cells. Mice were reconstituted for 10–11 wk following which
BM- and gingiva-derived cells were analyzed by FACS. Lineage output of BM and gingiva HSPC-derived progeny in the BM, blood, and spleen expressed as a
percentage of total donor HSPC-derived cells. n = 3–5 mice per group from two independent experiments. Data are presented as mean ± SEM, except in H and
I, where mean frequencies of HSPC-derived progeny are plotted. Statistical comparisons were performed using an unpaired t test (D and G) with Welch’s
correction (A–C) and a two-way ANOVA with a Holm–Š́ıdák post hoc test (F, H, and I); ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05.
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Figure S3. HSPCs in the gingiva and BM show altered responsiveness to inflammatory signals. (A) Single-cell RNA-seq analysis of total LSK + MyP cells
isolated by FACS from the gingiva and BM showing the annotation of identified lineages on the core model. (B–D) tSNE plots show the expression of erythroid
(B), myeloid (C), and lymphoid (D) lineage-associated gene transcripts projected onto the core model. (E–H) LIP was induced in cohorts of mice, at day 10 after
ligature placement, and gingiva HSPCs were FACS sorted from the gingiva. HSPCs were FACS sorted from naive gingiva as a control. (E) CFU activity from
MethoCult cultures of sorted LSK and MyP. (F) Quantification of neutrophil output from MethoCult cultures of LSK sorted from control and LIP gingiva, as
assessed by flow cytometry. n = 2 from two independent experiments. (G and H) Total HSPCs (LSK + MyP) were sorted from the gingiva of control or LIP
CD45.1/2 mice and transferred into sublethally irradiated CD45.2 hosts along with total BM cells from CD45.1 mice. Mice were examined 10–11 wk after
reconstitution. (G) Quantification of HSPC-derived cellular progeny in indicated tissues expressed as a percentage of the total CD45+ population. (H) Neu-
trophil output as a proportion of CD45+ cells from control or LIP gingival HSPCs in the BM, blood, and spleen expressed as a percentage of total donor HSPC-
derived cells. n = 3–4 per group from two independent experiments. (I and J) Fold-change in the percentages of LSK (I) and MyP (J) in the gingiva and BM 18 h
following i.p. administration of 5 µg LPS. n = 6–9 mice per group pooled from three experiments. Data are presented as the mean ± SEM. Statistical com-
parisons were performed using an unpaired t test (E and F) withWelch’s correction (H–J) and a two-way ANOVA with a Holm–Š́ıdák post hoc test (G); ****, P <
0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05.
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